Arrhythmogenic Cardiomyopathy in 2018: ARVC/ALVC or Both?

Main|Search|PHGKB


Last Posted: Nov 21, 2018

---

• Arrhythmogenic Cardiomyopathy in 2018: ARVC/ALVC or Both?
  Bennett Richard G et al. Heart, lung & circulation 2018 Oct
• Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.
  Domínguez Fernando et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2471-2481
• Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
  Cirino Allison L et al. Cardiology clinics 2019 Feb 37(1) 35-43
• The Clinical Course of a Genetic Dilated Cardiomyopathy: Letting the Cat Out of the BAG3.
  Shaw Robin M et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2482-2484
• Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
  Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606
• Modeling Hypertrophic Cardiomyopathy in a Dish
  NIH Director's Blog, November 8, 2018
• The genetics of hypertrophic cardiomyopathy.
  Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36
• A stroke gene panel for whole-exome sequencing.
  Ilinca Andreea et al. European journal of human genetics : EJHG 2018 Oct
• Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
  Naik Rakhi P, et al. Annals of internal medicine 2018 11 0. (9) 619-627
• Genotype-Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy.
  Li Shijie et al. Journal of the American Heart Association 2018 Oct 7(20) e009910

more